Zymeworks Inc
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult to treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks' suite of…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) R&D and clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, focused on treatment of cancer and autoimmune diseases. Zymeworks' suite of complementary…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) R&D and clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks' suite of complementary therapeutic…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) R&D and clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks' suite of complementary therapeutic…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) R&D and clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks' suite of complementary therapeutic…
Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) R&D and clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks' suite of complementary therapeutic…